Top movers in Wednesday's after hours session
By Mill Chart
Last update: Apr 17, 2024
Get insights into the top gainers and losers of Wednesday's after-hours session.
After hours gainers
| Ticker | Change | Comment |
|---|---|---|
| TIRX | 56.87% | TIAN RUIXIANG HOLDINGS LTD-A (NASDAQ:TIRX) rose 56.87% to $0.76 during Wednesday's after hours session. In the last 6 months the share price dropped with 48.76%. |
| TRVN | 44.25% | TREVENA INC's (NASDAQ:TRVN) stock price increased by 44.25% to $0.58. The stock is trading 28.55% lower than a month ago. |
| MBIO | 13.16% | MUSTANG BIO INC (NASDAQ:MBIO) showcases remarkable after-hours performance, with a 13.16% rise to $0.43 during Wednesday's after-hours trading. In the last month the share price dropped with 66.71%. |
| SINT | 12.87% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares rose 12.87% to $0.04 during Wednesday's after hours session. The strong performance observed in the regular session, where NASDAQ:SINT registered a 62.88% gain, continues to drive positive movement in the after-hours session. |
| GRTX | 12.75% | GALERA THERAPEUTICS INC's (NASDAQ:GRTX) stock price increased by 12.75% to $0.22. The positive market sentiment seen in today's regular session, where NASDAQ:GRTX closed with a 16.71% gain, carries over into the after-hours session. |
| IZM | 12.52% | After the regular session, ICZOOM GROUP INC -CLASS A (NASDAQ:IZM) continues to impress in the after-hours session, with a 12.52% increase to $6.74. After today's drop of -88.26%, it looks like it is bouncing back during today's after hours session. |
| IGC | 7.43% | IGC PHARMA INC (NYSEARCA:IGC) exhibits strong performance after hours, with shares rising 7.43% to $0.63 during Wednesday's after-hours session. Today's 20.68% gain extends further in today's after-hours session with an additional 7.43% increase. Two days ago the company had a press release: IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two. |
| UAMY | 6.79% | UNITED STATES ANTIMONY CORP's (NYSEARCA:UAMY) stock price is advancing with 6.79% to a price of $0.26. The stock is trading 29.49% lower than 6 months ago. |
| XELA | 5.98% | After the regular session, EXELA TECHNOLOGIES INC (NASDAQ:XELA) continues to impress in the after-hours session, with a 5.98% increase to $2.48. In the last 6 months the stock lost 22.7%. |
| SXTC | 5.08% | Positive market activity for CHINA SXT PHARMACEUTICALS IN (NASDAQ:SXTC) after regular trading hours, with a 5.08% increase to $1.24 in the after-hours session on Wednesday. Following a -27.16% loss in the regular session, NASDAQ:SXTC displays significant price volatility in today's after-hours session. |
Our after hours gainers page will show you the full list.
Today's after hours losers
| Ticker | Change | Comment |
|---|---|---|
| SNGX | -13.73% | SOLIGENIX INC's (NASDAQ:SNGX) shares experienced a 13.73% decrease to $0.44 in the after-hours session. In the last month the share price dropped with 22.62%. |
| MOTS | -12.85% | Today's after-hours session sees a continuation of the -34.06% decrease earlier in the day for NASDAQ:MOTS. It appears that the downward trend persists as NASDAQ:MOTS also experienced a -34.06% decline during the regular session. |
| TCON | -10.92% | TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) shares declined by 10.92% to $2.04 during Wednesday's after-hours session. After registering a 33.92% gain earlier today, NASDAQ:TCON is experiencing a 10.92% decline in today's after-hours session. |
| ICU | -10.85% | SEASTAR MEDICAL HOLDING CORP's (NASDAQ:ICU) stock price is showing a decline of 10.85% to a price of $0.62 during the after-hours session. In the last 6 months the stock lost 30.36%. |
| INVO | -9.34% | INVO BIOSCIENCE INC's (NASDAQ:INVO) stock price is declining with 9.34% to a price of $1.65. Price movements remain volatile as NASDAQ:INVO gives back 139.0% of its earlier gains in the after-hours session. |
| TKC | -8.71% | TURKCELL ILETISIM HIZMET-ADR's (NYSE:TKC) shares declined by 8.71% to $5.11 during Wednesday's after-hours session. In the last 6 months the stock gained 26.15%. |
| NA | -7.43% | NANO LABS LTD's (NASDAQ:NA) stock price is showing a decline of 7.43% to a price of $0.5 during the after-hours session. In the last month the stock lost 68.06%. |
| TPET | -7.29% | Price volatility persists as NYSEARCA:TPET closed the regular session with a -30.31% loss, and the downward trend continues in the after-hours session. The after-hours session reflects NYSEARCA:TPET's ongoing correction after a -30.31% loss in the regular trading hours. |
| EFX | -7.02% | EQUIFAX INC's (NYSE:EFX) stock price is declining with 7.02% to a price of $221.0. The company's earnings where released Yesterday. Shareholders saw the stock price going 35.27% higher is the past 6 months. |
| RCON | -5.62% | RECON TECHNOLOGY LTD-CLASS A's (NASDAQ:RCON) stock price is declining with 5.62% to a price of $0.09. In the last month the share price dropped with 20.8%. |
To see the full list of after hours losers you can use our after hours losers page.
SOLIGENIX INC
NASDAQ:SNGX (5/17/2024, 8:28:34 PM)
After market: 0.385 -0.01 (-1.94%)0.3926
+0 (+0.67%)
SNGX News
3 days ago - Soligenix, Inc.Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
6 days ago - BusinessInsiderSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ:SNGX) just reported results for the first quarter of 2024.Sol...
6 days ago - InvestorPlaceSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024SNGX stock results show that Soligenix beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
9 days ago - ChartmillWhich stocks are moving after the closing bell on Friday?What's going on in today's after hours session
9 days ago - Soligenix, Inc.Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
13 days ago - Soligenix, Inc.Soligenix to Present at Upcoming Conferences/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
24 days ago - Soligenix, Inc.Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
a month ago - Soligenix, Inc.Soligenix Announces Pricing of $4.75 Million Public Offering/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayPre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!
On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i
a month ago - InvestorPlaceWhy Are Stocks Up Today?Stocks are up today and investors wondering what's behind that rally have come to the right place as we have the latest news for Monday!
